Publication

(Phospho)creatine: the reserve and merry-go-round of brain energetics

Downloadable Content

Persistent URL
Last modified
  • 06/17/2025
Type of Material
Authors
    Hong-Ru Chen, University of VirginiaAntonuis DeGrauw, Emory UniversityChia-Yi Kuan, Emory University
Language
  • English
Date
  • 2023-02-01
Publisher
  • WOLTERS KLUWER MEDKNOW PUBLICATIONS
Publication Version
Copyright Statement
  • © Neural Regeneration Research
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 18
Issue
  • 2
Start Page
  • 327
End Page
  • 328
Grant/Funding Information
  • This work was supported by the NIH grant NS108763 (to CYK).
Abstract
  • Creatine transporter (CrT)-deficiency, the most common form of the cerebral creatine deficiency syndromes, causes cognition impairments and severe reduction of the brain creatine (Cr) and phosphocreatine (PCr) levels, and responds poorly to oral Cr supplement as a treatment option. The causes of cognitive impairments in CrT-deficient children remain unclear. We recently use gene-targeting to create a mouse model of CrT-deficiency to assess the impacts of Cr/PCr deficiency on brain energetics and stress-adaptation responses (Chen et al., 2021). We found that Cr/PCr-deficiency impairs the development of dendritic spines and synapses, skews the balance of mechanistic target of rapamycin (mTOR) and autophagy signaling towards catabolism, and elevates the sensitivity to external stress, including ischemia or hypoxia, to cause greater brain injury. Notably, intranasal delivery of Cr after cerebral ischemia raises the brain Cr/PCr levels and reduces the infarct size in CrT-null mice, despite Cr itself lacking a high-energy phosphoryl group. These findings highlight a critical role of Cr/PCr for maintaining brain energetics and suggest potential therapies of CrT-deficiency.
Author Notes
Keywords
Research Categories
  • Health Sciences, Medicine and Surgery

Tools

Relations

In Collection:

Items